FLOT Is Superior to ECF/ECX Among Patients With Gastric Cancer
A new study shared at ASCO showed perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin significantly improved survival among patients with resectable gastric cancers.
Read Source